Europe Venous Thromboembolism Epidemiology and Patient Flow Analysis - 2018 - ResearchAndMarkets.com
Jul. 10, 2018
DUBLIN--(BUSINESS WIRE)--Jul 10, 2018--The "Europe Venous Thromboembolism Epidemiology and Patient Flow Analysis - 2018" report has been added to ResearchAndMarkets.com's offering.
The researcher announced the results of its Venous Thromboembolism patients study in a new research Europe Venous Thromboembolism Epidemiology and Patient Flow Analysis - 2018'. The research provides insights into Venous Thromboembolism epidemiology, Venous Thromboembolism diagnosed patients, and Venous Thromboembolism treatment rate for EU5 countries. The research measures key indicators including prevalence of Venous Thromboembolism derived from epidemiological analysis, patients diagnosed with Venous Thromboembolism, and patients treated with a drug therapy.
The research study helps executives estimate Venous Thromboembolism market potential, assess unmet need, develop drug forecasting models, and build population-based health management frameworks. The information presented in this study is used to evaluate market opportunities, effectively identify target patient population, and align marketing decisions.
The research provides estimates and forecasts of Venous Thromboembolism prevalence, Venous Thromboembolism diagnosis rate, and Venous Thromboembolism treatment rate for the period 2017 - 2026. The information is presented by EU5 countries including Germany, France, Spain, Italy, and UK.
For more information about this report visit https://www.researchandmarkets.com/research/tmf9vq/europe_venous?w=4
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
View source version on businesswire.com:https://www.businesswire.com/news/home/20180710005667/en/
Laura Wood, Senior Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics:Cardiovascular Drugs
INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL
SOURCE: Research and Markets
Copyright Business Wire 2018.
PUB: 07/10/2018 10:32 AM/DISC: 07/10/2018 10:32 AM